Publications by authors named "V Shoshan-Barmatz"

Mitochondria serve as central hubs for regulating numerous cellular processes that include metabolism, apoptosis, cell cycle progression, proliferation, differentiation, epigenetics, immune signaling, and aging. The voltage-dependent anion channel 1 (VDAC1) functions as a crucial mitochondrial gatekeeper, controlling the flow of ions, such as Ca, nucleotides, and metabolites across the outer mitochondrial membrane, and is also integral to mitochondria-mediated apoptosis. VDAC1 functions in regulating ATP production, Ca homeostasis, and apoptosis, which are essential for maintaining mitochondrial function and overall cellular health.

View Article and Find Full Text PDF

Mitochondria dysfunction is implicated in cell death, inflammation, and autoimmunity. During viral infections, some viruses employ different strategies to disrupt mitochondria-dependent apoptosis, while others, including SARS-CoV-2, induce host cell apoptosis to facilitate replication and immune system modulation. Given mitochondrial DNAs (mtDNA) role as a pro-inflammatory damage-associated molecular pattern in inflammatory diseases, we examined its levels in the serum of COVID-19 patients and found it to be high relative to levels in healthy donors.

View Article and Find Full Text PDF

This review presents current knowledge related to the voltage-dependent anion channel-1 (VDAC1) as a multi-functional mitochondrial protein that acts in regulating both cell life and death. The location of VDAC1 at the outer mitochondrial membrane (OMM) allows control of metabolic cross-talk between the mitochondria and the rest of the cell, and also enables its interaction with proteins that are involved in metabolic, cell death, and survival pathways. VDAC1's interactions with over 150 proteins can mediate and regulate the integration of mitochondrial functions with cellular activities.

View Article and Find Full Text PDF
Article Synopsis
  • Alterations in cellular metabolism are crucial for cancer cell development, and this study investigates the impact of silencing the mitochondrial protein VDAC1 on lung cancer growth and characteristics using a mouse model.
  • Administration of the VDAC1-silencing treatment (si-m/hVDAC1-B) via nanoparticles significantly reduced tumor size and number in mice, while control mice developed large tumors, highlighting the treatment's effectiveness.
  • The research also identifies changes in cell markers and tumor morphology, confirming the treatment targets both small cell (SCLC) and non-small cell (NSCLC) lung cancer, suggesting its potential as a new therapeutic approach against these types.
View Article and Find Full Text PDF